A Phase III, International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects with Pulmonary Arterial HTN Receiving Background Oral Monotherapy

  • Brown, Martin (Primary Chief Investigator)
  • Butala, Radhika (Associate Investigator)

    Project: Research

    Project Details

    StatusFinished
    Effective start/end date1/11/15 → 30/11/18